Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Migraine in Adolescents
NL-OMON21202Active, not recruiting
- Sponsor
- NUTSHELL Therapeutics
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of propranolol in migraine (2 arms), sponsored by NUTSHELL Therapeutics. Primary endpoints: Perceived effect, Change in intensity of migraine attacks and 2 more. Started Oct 2006; status: active, not recruiting.
02
Drugs
propranolol
03
Conditions
migraine
Beyond the preview
Go deeper on NL-OMON21202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21202.